W.R. Grace & Co. (GRA) Tops Q4 EPS by 2c; Guides FY12 Revs, Adj.-EBIT Growth
Tweet
Share
E-mailGet Alerts GRA Hot Sheet
Price: $69.99 --0%
Financial Fact:
Research and development expenses: 12.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: 12.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
W.R. Grace & Co. (NYSE: GRA) reported Q4 EPS of $0.89, $0.02 better than the analyst estimate of $0.87. Revenue for the quarter came in at $825.6 million, versus $693 million reported last year.
Sees FY2012 revenue of $3.25-$3.35 billion, and adjusted EBIT up 6 - 11 percent.
For earnings history and earnings-related data on W.R. Grace & Co. (GRA) click here.
Sees FY2012 revenue of $3.25-$3.35 billion, and adjusted EBIT up 6 - 11 percent.
For earnings history and earnings-related data on W.R. Grace & Co. (GRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
